Annual report pursuant to Section 13 and 15(d)

Investment in Affiliated Companies, Net - Schedule of Paid in Investment (Details) (Parenthetical)

v3.21.1
Investment in Affiliated Companies, Net - Schedule of Paid in Investment (Details) (Parenthetical)
$ in Thousands
12 Months Ended
Dec. 31, 2020
USD ($)
shares
Funding commitment $ 1,550 [1]
Number of common stock shares issued as finder fee | shares 2,164,502
Antigen COVID Test Killer [Member]  
Funding commitment $ 911
[1] An amount of $911 out of the Funding commitment was wired through December 31, 2020.